Iron-deficiency Vitamine D-deficiency
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: -Apparently healthy male and female subjects between 12 and 36 months of age -Stable health status (i.e. being unknown with chronic or recent acute diseases) and expected to remain stable -Familiar with and currently drinking milk products; expected study product intake of 300-500 ml per day - Written informed consent from parents
Exclusion criteria
Exclusion criteria: - Known infection during the last week or infection needing medical assistance or treatment during the last 2 weeks - Any case of anaemia treated with pharmaceutical product in the last three months - Any relevant congenital abnormality, chromosomal disorder or severe disease (such as tracheoesophageal fistula, tracheomalacia, major congenital heart disease, Down*s syndrome, HIV, cancer) - Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps for which special toddler formula is required) - Current use of anti-regurgitation, anti-reflux or laxative medication - Known hemoglobinopathies or thalassaemia - Blood transfusion received within the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome parameter in this study is the change in serum SF concentrations after 20 weeks of study product consumption. | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of ID and IDA after 20 weeks of study product consumption - ID is defined as SF | — |
Countries
Netherlands